Symbols

PRGO

Perrigo·NYSE

--(--)

PRGO fundamentals

PRGO Q4 2025 Earnings

Perrigo (PRGO) released its earnings on Feb 26, 2026: revenue was 1.11B (YoY -2.52%), beat estimates; EPS was 0.77 (YoY -17.20%), missed estimates.

Revenue / YoY

1.11B

-2.52%

EPS / YoY

0.77

-17.20%

Report date

Feb 26, 2026

PRGO Earnings Call Summary for Q4,2025

2025 Performance: CORE Perrigo EPS up 14% to $2.75, driven by 7% operating income growth. Q4 organic sales declined 2% vs. 2024, but share gains accelerated.
2026 Outlook: CORE EPS $2.25-$2.55, with H2 recovery fueled by 65% of innovation pipeline and 70% of distribution gains. Under-absorption to cost $0.60 EPS.
Cost Savings: $80-100M annual savings from operational enhancements, offsetting $80-90M transition costs.
Infant Formula: 2-4% 2026 sales growth to clear high-margin inventory; strategic review evaluating plant optimization.
Leverage & Cash Flow: Net leverage ~4x in 2026; Dermacosmetics sale proceeds to reduce debt.

Earnings

EPS

Revenue

Revenue & Expenses

PRGO has released its 2025 Q4 earnings report, with revenue of 1.11B, reflecting a YoY change of -2.52%, and net profit of -1.42B, showing a YoY change of -3086.74%. The Sankey diagram below clearly presents PRGO's revenue sources and cost distribution.

Key Indicators

Perrigo (PRGO) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Perrigo (PRGO)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

Perrigo (PRGO)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

Perrigo (PRGO)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown